Switching depot antipsychotic drug responders to oral olanzapine

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 1, 2005, Pages 141-144

  Godleski, Linda S ^a,b   Goldsmith, L Jane ^b   Vieweg, W Victor R ^c   Zettwoch, Nancy ^a   Stikovac, Dejzi ^a,b   Lewis, Susan ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depot antipsychotics; Olanzapine; Psychotropic switching strategies

Indexed keywords

FLUPHENAZINE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PATIENT COMPLIANCE; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 10944228251     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.08.009     Document Type: Article

References (16)

1. O.P. Almeida Olanzapine for the treatment of tardive dyskinesia J. Clin. Psychiatry 59 1998 380 381
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders Fourth ed. 1994 American Psychiatric Association Washington, DC
3. Association for Methodology and Documentation in Psychiatry The AMDP system in clinical psychopharmacology Br. J. Psychiatry 148 1986 467 468
4. C.M. Beasley, G.D. Tollefson, and P.V. Tran Safety of olanzapine J. Clin. Psychiatry 58 Suppl. 10 1997 13 17
5. M.H. Bunn, A.M. O'Connor, M.S. Tansey, B.D. Jones, and L.E. Stinson Characteristics of clients with schizophrenia who express certainty or uncertainty about continuing treatment with depot neuroleptic medication Arch. Psychiatr. Nurs. 11 1997 238 248
6. G. Chouinard, A. Ross-Chouinard, L. Annable, and B.D. Jones The extrapyramidal symptom rating scale Can. J. Neurol. Sci. 7 1980 233
7. Eli Lilly and Company. Zyprexa Package Insert. Eli Lilly and Company, 1-24. 9-16-2003.
8. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
9. J. Garavan, S. Browne, M. Gervin, A. Lane, C. Larkin, and E. O'Callaghan Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight Compr. Psychiatry 39 1998 215 219
10. J. Gerlach, and E.B. Larsen Subjective experience and mental side-effects of antipsychotic treatment Acta Psychiatr. Scand., Suppl. 395 1999 113 117
11. L.S. Godleski, L.J. Goldsmith, W.V.R. Vieweg, N.C. Zettwoch, D.J. Stikovac, and S.J. Lewis Switching from depot antipsychotic drugs to olanzapine in patients with chronic schizophrenia J. Clin. Psychiatry 64 2003 119 122
12. W. Guy Abnormal involuntary movement scale ECDEU Assessment Manual for Psychopharmacology (ADM 76-338). US Department of Health, Education, and Welfare 1976 National Institute for Mental Health Rockville, MD 218 222
13. W. Guy Clinical global impressions ECDEU Assessment Manual for Psychopharmacology (ADM 76-338). US Department of Health, Education, and Welfare 1976 National Institute for Mental Health Rockville, MD 217 222
14. S.R. Kay, A. Fiszbein, and L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
15. A. Labelle, D. Bourget, L.J. Boulay, J. Ellis, and P. Tessier Switching outpatients with schizophrenia and related disorders on long-acting injectable antipsychotics to olanzapine: an open-label naturalistic pilot study J. Clin. Psychopharmacol. 22 2002 545 553
16. K.H. Littrell, C.G. Johnson, N.M. Hilligoss, C.D. Peabody, and S.H. Littrell Switching clozapine responders to olanzapine J. Clin. Psychiatry 61 2000 912 915